Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qingdao Haosail Science is a marine biotechnology company specializing in the research, development, and large-scale production of microalgae-based nutritional ingredients. The company's core product portfolio includes docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), arachidonic acid (ARA), and various carotenoids like astaxanthin and beta-carotene. These ingredients are supplied to the global food, dietary supplement, pharmaceutical, and animal nutrition industries. Haosail operates advanced fermentation and extraction facilities to ensure high-purity, sustainable alternatives to fish-derived oils. The company is recognized for its expertise in microencapsulation, providing stabilized powder forms of sensitive lipids for diverse applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qingdao Haosail Science.